SAN DIEGO--(BUSINESS WIRE)--Hollis-Eden Pharmaceuticals, Inc. (NASDAQ:HEPH), the leader in the development of a new class of small molecule compounds based on endogenous steroid hormones, today announced that it will conduct a conference call and live webcast on August 7, 2008 at 2:00 p.m. EDT (11:00 a.m. PDT) to discuss its second quarter 2008 financial results and to update its drug development programs in metabolic disorders, inflammatory conditions and cancer. The Company will release its financial results prior to the market opening that day.
